Main demographic and clinical characteristics of study patients
. | Data . |
|---|---|
| No. of patients | 1754 |
| Age, y, mean ± SD | 66 ± 18 |
| Sex, no. M/no. F | 826/928 |
| Pregnancy, no. (%) | 32 (1.8) |
| Cancer, no. (%) | 268 (15.3) |
| Previous heparin exposure, no. (%) | |
| More than 3 mo earlier | 538 (30.7) |
| Within the previous 3 mo | 60 (3.4) |
| Setting of treatment, no. (%) | |
| Entirely in the hospital | 816 (46.5) |
| Primarily at home | 938 (53.5) |
| Indication for LMWH therapy, no. (%) | |
| Prevention of VTE | 452 (25.8) |
| Treatment of VTE | 530 (30.2) |
| Atrial fibrillation | 320 (18.2) |
| Coronary artery disease | 187 (10.7) |
| Cerebrovascular disease | 108 (6.2) |
| Other | 157 (8.9) |
| LMWH dosage, no. (%) | |
| Fixed low-dose | 376 (21.4) |
| Therapeutic adjusted-dose | 728 (41.5) |
| Intermediate dose | 650 (37.1) |
| LMWH type, no. (%) | |
| Nadroparin | 880 (45.6) |
| Enoxaparin | 700 (39.9) |
| Reviparin | 67 (3.8) |
| Dalteparin | 64 (3.6) |
| Parnaparin | 43 (2.4) |
| LMWH duration, d, median (range) | 8 (2-30) |
. | Data . |
|---|---|
| No. of patients | 1754 |
| Age, y, mean ± SD | 66 ± 18 |
| Sex, no. M/no. F | 826/928 |
| Pregnancy, no. (%) | 32 (1.8) |
| Cancer, no. (%) | 268 (15.3) |
| Previous heparin exposure, no. (%) | |
| More than 3 mo earlier | 538 (30.7) |
| Within the previous 3 mo | 60 (3.4) |
| Setting of treatment, no. (%) | |
| Entirely in the hospital | 816 (46.5) |
| Primarily at home | 938 (53.5) |
| Indication for LMWH therapy, no. (%) | |
| Prevention of VTE | 452 (25.8) |
| Treatment of VTE | 530 (30.2) |
| Atrial fibrillation | 320 (18.2) |
| Coronary artery disease | 187 (10.7) |
| Cerebrovascular disease | 108 (6.2) |
| Other | 157 (8.9) |
| LMWH dosage, no. (%) | |
| Fixed low-dose | 376 (21.4) |
| Therapeutic adjusted-dose | 728 (41.5) |
| Intermediate dose | 650 (37.1) |
| LMWH type, no. (%) | |
| Nadroparin | 880 (45.6) |
| Enoxaparin | 700 (39.9) |
| Reviparin | 67 (3.8) |
| Dalteparin | 64 (3.6) |
| Parnaparin | 43 (2.4) |
| LMWH duration, d, median (range) | 8 (2-30) |